<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article208</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index_gpt.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/Albumin_for_SBP" style="display:block; margin-bottom:10px;">Albumin for SBP Original</a></li>
<h2><strong>Albumin for SBP</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Albumin Infusion in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis".The New England Journal of Medicine. 1999. 341(6):403-409.PubMed•Full text•PDF<br/>
<br/>
<h2><strong>Contents</strong></h2><br/>
1Clinical Question<br/>
2Bottom Line<br/>
3Major Points<br/>
4Guidelines<br/>
5Design<br/>
6Population<br/>
6.1Inclusion Criteria<br/>
6.2Exclusion Criteria<br/>
6.3Baseline Characteristics<br/>
7Interventions<br/>
8Outcomes<br/>
8.1Primary Outcomes<br/>
8.2Secondary Outcomes<br/>
9Funding<br/>
10Further Reading<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
In patients with cirrhosis and spontaneous bacterial peritonitis, does plasma volume expansion with intravenous albumin prevent renal impairment and reduce mortality?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In patients with cirrhosis and spontaneous bacterial peritonitis, treatment with intravenous albumin in addition to antibiotics significantly decreases the incidence of renal impairment and improves survival compared with antibiotics alone.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/>
Spontaneous bacterial peritonitis is a severe complication in patients with cirrhosis. One-third of these patients develop renal impairment during the infection despite non-nephrotoxic antibiotic treatment, which is associated with higher mortality. Plasma volume expansion with albumin may enhance arterial blood volume, thus preventing circulatory dysfunction and kidney damage.<br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
As of the current knowledge cutoff, the updated guidelines reflecting the results of this study have not been provided.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
Multicenter, double-blind, randomized, controlled trial.<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
N=126 patients with cirrhosis and spontaneous bacterial peritonitis. <br/>
<br/>
Inclusion Criteria<br/>
- Polymorphonuclear-cell count in ascitic fluid &gt;250/mm^3<br/>
- Age between 18 and 80 years<br/>
- Serum creatinine ≤3 mg/dL (265 μmol/L)<br/>
<br/>
Exclusion Criteria<br/>
- Antibiotic treatment within one week before diagnosis<br/>
- Other infections, shock, severe hepatic encephalopathy, cardiac failure, organic nephropathy, HIV<br/>
- Dehydration causes within one week before diagnosis<br/>
<br/>
Baseline Characteristics<br/>
The groups were well-matched in terms of clinical and laboratory data at enrollment. <br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
Two groups: cefotaxime alone (n=63) vs. cefotaxime and intravenous albumin (n=63).<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcomes<br/>
- Development of renal impairment<br/>
- Mortality during hospitalization and at three months<br/>
<br/>
Secondary Outcomes<br/>
- Resolution of infection <br/>
- Increased plasma renin activity<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
Supported by grants from the Fondo de Investigación Sanitaria (FIS 94/0956 and FIS 96/1723) and the Hospital Clínic.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
Original article in The New England Journal of Medicine, 1999. 341(6):403-409.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
